Tandem Diabetes Care, Inc.: Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technology in Children and Adults

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced real-world data confirming that use of the t:slim X2 insulin pump with Control-IQ advanced

Related Keywords

Italy ,Sweden ,California ,United States ,San Diego ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Steph Habif ,Andreae Scaramuzza ,Halland Kungsbacka ,Peter Adolfsson ,Steve Sabicer ,Susan Morrison ,Tandem Diabetes Care Inc ,International Presentations Including Technology ,Nasdaq ,Us Presentations Including Technology ,Health Economy After Implementation Of Tandem Technology ,Behavioral Sciences ,International Conference On Advanced Technologies ,Year Follow Up On Technology ,Department Of Pediatrics ,Previous Insulin Delivery Method In Technology Users ,Tandem Diabetes Care ,International Conference ,Advanced Technologies ,Jordan Pinsker ,Vice President ,Medical Director ,Tandem Diabetes ,Longitudinal Study Results ,Patient Reported Outcomes ,Advanced Hybrid Closed Loop Therapy ,Related Glycemic Outcomes ,Azienda Socio Sanitaria Territoriale ,Baseline Glycemic Control ,Previous Insulin Delivery Method ,Annual International Conference ,Advanced Technologies Treatments ,Multiple Daily ,Virtual Pediatric ,Prospective Controlled Study Evaluating ,Long Term Outcomes ,Glucose Control ,Health Economy After Implementation ,Pediatric Population ,Diabetes Care ,Safety Information ,Tandem ,Diabetes ,Mare ,Meal ,World ,Evidence ,Onfirms ,Immediate ,Ngoing ,Performance ,Muslim ,Insulin ,Pump ,Control ,Technology ,Children ,Adults ,